Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low-risk of upgrade to invasive carcinoma? Meeting Abstract


Authors: Pilewskie, M.; Stempel, M.; Rosenfeld, H.; Eaton, A.; Van Zee, K. J.; Morrow, M.
Abstract Title: Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low-risk of upgrade to invasive carcinoma?
Meeting Title: 69th Annual Cancer Symposium of the Society of Surgical Oncology (SSO)
Journal Title: Annals of Surgical Oncology
Volume: 23
Issue: 1 Suppl.
Meeting Dates: 2016 Mar 2-5
Meeting Location: Boston, MA
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2016-02-01
Start Page: S25
End Page: S26
Language: English
ACCESSION: WOS:000368185000053
PROVIDER: wos
PUBMED: 26745989
DOI: 10.1245/s10434-015-5010-5
Notes: Meeting Abstract: 52 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Morrow
    772 Morrow
  2. Kimberly J Van Zee
    293 Van Zee
  3. Anne Austin Eaton
    122 Eaton
  4. Michelle Moccio Stempel
    153 Stempel
  5. Melissa Louise Pilewskie
    112 Pilewskie
Related MSK Work